Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor

被引:76
|
作者
Miao, Yinglong [1 ,2 ]
Goldfeld, Dahlia Anne [2 ]
Von Moo, Ee [3 ]
Sexton, Patrick M. [3 ]
Christopoulos, Arthur [3 ]
McCammon, J. Andrew [1 ,2 ,4 ]
Valant, Celine [3 ]
机构
[1] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[3] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia
[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
基金
美国国家科学基金会; 英国医学研究理事会;
关键词
GPCR; allosteric modulators; ensemble docking; affinity; cooperativity; MOLECULAR-DYNAMICS SIMULATIONS; RELAXED COMPLEX SCHEME; ACETYLCHOLINE-RECEPTORS; DRUG DISCOVERY; INTERNATIONAL UNION; BINDING-SITES; ACTIVATION; TARGETS; CLASSIFICATION; PHARMACOLOGY;
D O I
10.1073/pnas.1612353113
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Design of ligands that provide receptor selectivity has emerged as a new paradigm for drug discovery of G protein-coupled receptors, and may, for certain families of receptors, only be achieved via identification of chemically diverse allosteric modulators. Here, the extracellular vestibule of the M-2 muscarinic acetylcholine receptor (mAChR) is targeted for structure-based design of allosteric modulators. Accelerated molecular dynamics (aMD) simulations were performed to construct structural ensembles that account for the receptor flexibility. Compounds obtained from the National Cancer Institute (NCI) were docked to the receptor ensembles. Retrospective docking of known ligands showed that combining aMD simulations with Glide induced fit docking (IFD) provided much-improved enrichment factors, compared with the Glide virtual screening workflow. Glide IFD was thus applied in receptor ensemble docking, and 38 top-ranked NCI compounds were selected for experimental testing. In [H-3]N-methylscopolamine radioligand dissociation assays, approximately half of the 38 lead compounds altered the radioligand dissociation rate, a hallmark of allosteric behavior. In further competition binding experiments, we identified 12 compounds with affinity of <= 30 mu M. With final functional experiments on six selected compounds, we confirmed four of them as new negative allosteric modulators (NAMs) and one as positive allosteric modulator of agonist-mediated response at the M-2 mAChR. Two of the NAMs showed subtype selectivity without significant effect at the M-1 and M-3 mAChRs. This study demonstrates an unprecedented successful structure-based approach to identify chemically diverse and selective GPCR allosteric modulators with outstanding potential for further structure-activity relationship studies.
引用
收藏
页码:E5675 / E5684
页数:10
相关论文
共 50 条
  • [21] Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine
    Waldschmidt, Helen V.
    Homan, Kristoff T.
    Cato, Marilyn C.
    Cruz-Rodriguez, Osvaldo
    Cannavo, Alessandro
    Wilson, Michael W.
    Song, Jianliang
    Cheung, Joseph Y.
    Koch, Walter J.
    Tesmer, John J. G.
    Larsen, Scott D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (07) : 3052 - 3069
  • [22] Toward G protein-coupled receptor structure-based drug design using X-ray lasers
    Ishchenko, Andrii
    Stauch, Benjamin
    Han, Gye Won
    Batyuk, Alexander
    Shiriaeva, Anna
    Li, Chufeng
    Zatsepin, Nadia
    Weierstall, Uwe
    Liu, Wei
    Nango, Eriko
    Nakane, Takanori
    Tanaka, Rie
    Tono, Kensuke
    Joti, Yasumasa
    Iwata, So
    Moraes, Isabel
    Gati, Cornelius
    Cherezov, Vadim
    IUCRJ, 2019, 6 : 1106 - 1119
  • [23] AGONISTS, INVERSE AGONISTS, AND ALLOSTERIC MODULATORS OF G PROTEIN-COUPLED RECEPTORS
    Pardo, Leonardo
    DRUGS OF THE FUTURE, 2009, 34 : 4 - 5
  • [24] Structure-Based Discovery of Allosteric Modulators of Two Related Class B G-Protein-Coupled Receptors
    de Graaf, Chris
    Rein, Chantal
    Piwnica, David
    Giordanetto, Fabrizio
    Rognan, Didier
    CHEMMEDCHEM, 2011, 6 (12) : 2159 - 2169
  • [25] Artificial Intelligence: A New Tool for Structure-Based G Protein-Coupled Receptor Drug Discovery
    Chung, Jason
    Hahn, Hyunggu
    Flores-Espinoza, Emmanuel
    Thomsen, Alex R. B.
    BIOMOLECULES, 2025, 15 (03)
  • [26] Stabilised G protein-coupled receptors in structure-based drug design: a case study with adenosine A2A receptor
    Andrews, Stephen P.
    Tehan, Benjamin
    MEDCHEMCOMM, 2013, 4 (01) : 52 - 67
  • [27] Allosteric regulation of G protein-coupled receptor activity by phospholipids
    Dawaliby R.
    Trubbia C.
    Delporte C.
    Masureel M.
    Van Antwerpen P.
    Kobilka B.K.
    Govaerts C.
    Nature Chemical Biology, 2016, 12 (1) : 35 - 39
  • [28] Selective Photoswitchable Allosteric Agonist of a G Protein-Coupled Receptor
    Donthamsetti, Prashant
    Konrad, David B.
    Hetzler, Belinda
    Fu, Zhu
    Trauner, Dirk
    Isacoff, Ehud Y.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (24) : 8951 - 8956
  • [29] Allosteric regulation of G protein-coupled receptor activity by phospholipids
    Dawaliby, Rosie
    Trubbia, Cataldo
    Delporte, Cedric
    Masureel, Matthieu
    Van Antwerpen, Pierre
    Kobilka, Brian K.
    Govaerts, Cedric
    NATURE CHEMICAL BIOLOGY, 2016, 12 (01) : 35 - +
  • [30] Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
    Abdul-Ridha, Alaa
    Lane, J. Robert
    Sexton, Patrick M.
    Canals, Meritxell
    Christopoulos, Arthur
    MOLECULAR PHARMACOLOGY, 2013, 83 (02) : 521 - 530